Characteristics of Genomic Test Consumers Who Spontaneously Share Results With Their Health Care Provider

被引:21
作者
Darst, Burcu F. [1 ]
Madlensky, Lisa [2 ]
Schork, Nicholas J. [1 ,3 ]
Topol, Eric J. [1 ,3 ]
Bloss, Cinnamon S. [1 ]
机构
[1] Scripps Hlth, Scripps Translat Sci Inst, Scripps Genom Med, San Diego, CA USA
[2] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA
[3] Scripps Res Inst, Dept Mol & Expt Med, San Diego, CA USA
关键词
PERCEPTIONS;
D O I
10.1080/10410236.2012.717216
中图分类号
G2 [信息与知识传播];
学科分类号
05 ; 0503 ;
摘要
The purpose of this study was to evaluate the characteristics of direct-to-consumer (DTC) genomic test consumers who spontaneously shared their test results with their health care provider. Utilizing data from the Scripps Genomic Health Initiative, we compared demographic, behavioral, and attitudinal characteristics of DTC genomic test consumers who shared their results with their physician or health care provider versus those who did not share. We also compared genomic risk estimates between the two groups. Of 2,024 individuals assessed at approximately 6 months post testing, 540 individuals (26.5%) reported sharing their results with their physician or health care provider. Those who shared were older (p < .001), had a higher income (p = .01), were more likely to be married (p = .005), and were more likely to identify with a religion (p = .004). As assessed prior to undergoing testing, sharers also reported higher levels of exercise (p = .003), lower fat intake (p = .02), fewer overall concerns about testing (p = .001), and fewer concerns related to the privacy of their genomic information (p = .03). The genomic disease risk estimates disclosed were not associated with sharing. Thus, in a DTC genomic testing context, physicians and other health care providers may be more likely to encounter patients who are more health conscious and have fewer concerns about the privacy of their genomic information. Genomic risk itself does not appear to be a primary determinant of sharing behavior among consumers.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 10 条
[1]   Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk. [J].
Bloss, Cinnamon S. ;
Schork, Nicholas J. ;
Topol, Eric J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) :524-534
[2]   Consumer perceptions of direct-to-consumer personalized genomic risk assessments [J].
Bloss, Cinnamon S. ;
Ornowski, Laura ;
Silver, Elana ;
Cargill, Michele ;
Vanier, Vance ;
Schork, Nicholas J. ;
Topol, Eric J. .
GENETICS IN MEDICINE, 2010, 12 (09) :556-566
[3]  
Burke Wylie, 2009, Curr Protoc Hum Genet, VChapter 9, DOI 10.1002/0471142905.hg0915s60
[4]  
Healy M, 2009, LOS ANGELES TIMES
[5]   Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008 [J].
Kolor, Katherine ;
Liu, Tiebin ;
St Pierre, Jeanette ;
Khoury, Muin J. .
GENETICS IN MEDICINE, 2009, 11 (08) :595-595
[6]  
Maves M. D., 2011, COMMUNICATION
[7]   Characteristics of users of online personalized genomic risk assessments: Implications for physician-patient interactions [J].
McBride, Colleen M. ;
Alford, Sharon Hensley ;
Reid, Robert J. ;
Larson, Eric B. ;
Baxevanis, Andreas D. ;
Brody, Lawrence C. .
GENETICS IN MEDICINE, 2009, 11 (08) :582-587
[8]   Regulating Direct-to-Consumer Personal Genome Testing [J].
McGuire, Amy L. ;
Evans, Barbara J. ;
Caulfield, Timothy ;
Burke, Wylie .
SCIENCE, 2010, 330 (6001) :181-182
[9]   Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies [J].
Robinson, A ;
McGrail, MR .
COMPLEMENTARY THERAPIES IN MEDICINE, 2004, 12 (2-3) :90-98
[10]  
Sharp R. R., 2010, SCI TRANSLATIONAL ME, V2